A 66-year-old Vietnam-born Chinese man was admitted to our department because of progressive abdominal swelling and bilateral ankle oedema for 1 year. On physical examination, he was noted to have a short stature with body height of 1.37 m. He had a normal complexion and no other dysmorphic features. His blood pressure was 99/55 mm Hg but with no postural drop. Abdominal examination revealed a distended abdomen without organomegaly or shifting dullness. Examination of his external genitalia revealed a micropenis with perineoscrotal hypospadias (Prader stage IV); no testes could be detected in/along both the scrotum and inguinal canals. However, he had male pattern of escutcheon, a beard, and no gynaecomastia. On further questioning, he reluctantly disclosed a history of urinary leakage since childhood and arrest of growth after puberty at the age of 10 years. Computed tomography of the abdomen revealed a 13.6 x 26.5 x 23.7 cm non-enhancing septated cystic mass arising from the retrovesical region.
Case report
A 66-year-old Vietnam-born Chinese man was admitted to our department because of progressive abdominal swelling and bilateral ankle oedema for 1 year. On physical examination, he was noted to have a short stature with body height of 1.37 m. He had a normal complexion and no other dysmorphic features. His blood pressure was 99/55 mm Hg but with no postural drop. Abdominal examination revealed a distended abdomen without organomegaly or shifting dullness. Examination of his external genitalia revealed a micropenis with perineoscrotal hypospadias (Prader stage IV); no testes could be detected in/along both the scrotum and inguinal canals. However, he had male pattern of escutcheon, a beard, and no gynaecomastia. On further questioning, he reluctantly disclosed a history of urinary leakage since childhood and arrest of growth after puberty at the age of 10 years. Computed tomography of the abdomen revealed a 13.6 x 26.5 x 23.7 cm non-enhancing septated cystic mass arising from the retrovesical region.
Initial investigations revealed normal serum electrolytes and acid-base status. His renal function was impaired (serum creatinine of 172; reference range [RR], 62-126 μmol/L), and he had hypoalbuminaemia (serum albumin of 24; RR, 32-46 g/L). Baseline serum sex hormone profiles were as follows: testosterone at 9.2 (RR for male, 9.0-34.7) nmol/L, oestradiol at 176 (RR for male, 26-156) pmol/L, progesterone at 22.8 (RR for male, 0.7-4.3) nmol/L, luteinising hormone at 1.9 (RR, 1.7-8.6) IU/L, follicle-stimulating hormone at 3.0 (RR, 1.5-12.4) IU/L, androstenedione at 31.5 (RR, 0.8-3.1) nmol/L, and dehydroepiandrosterone sulfate at 11.6 (RR, 2.2-15.2) nmol/L. Tumour markers including beta-human chorionic gonadotropin, alpha-fetoprotein, carcinoembryonic antigen, and CA-125 were normal. A mosaic Turner karyotype with 10% monosomy X, 4% trisomy X, and 86% normal female karyotype was detected. The short synacthen test with 250 μg tetracosactrin was performed to unravel the possibility of congenital adrenal hyperplasia (CAH) with the following results: baseline adrenocorticotropic hormone (ACTH) at 50.2 (RR, <10.1) pmol/L; baseline and 60-minute post-stimulation serum cortisol at 224 and at 260 nmol/L, respectively (reference level, >550 nmol/L post-stimulation); and baseline and 60-minute post-stimulation 17-hydroxyprogesterone (17-OHP) at 70 and 554 nmol/L, respectively (reference level of classical CAH, >300 nmol/L). Urinary steroid profiling (USP) by gas chromatography-mass spectrometry (GC-MS) showed grossly elevated metabolites of 17-OHP (Fig 1) , including pregnanetriol, 17-hydroxypregnenolone and 11-oxo-pregnanetriol, compatible with 21-hydroxylase deficiency (21-OHD). Mutational analysis of the CYP21A2 gene by multiplex ligation-dependent probe amplification and by polymerase chain reaction (PCR) followed by direct DNA sequencing showed deletion/ conversion of the promoter to exon 4 in one allele and a hemizygous p.Ile172Asn mutation in the other allele. Using PCR no SRY gene could be amplified in the peripheral leukocytes and the surgical specimen (see below), which strongly reduced the possibility of hidden X/XY mosaicism or translocation of a Y-segment. 
Hydrocortisone replacement was started and laparotomy was performed under steroid cover 8 months after the diagnosis. Apart from the large cystic mass which was later confirmed histologically to be a right ovarian mucinous cyst, findings during surgery included the left ovary, an atrophic uterus, and both fallopian tubes, all of which were then removed (Fig 2) . No evidence of Wolffian structure could be identified. The postoperative course was uneventful and the diagnosis was disclosed to patient. The patient decided to continue perceiving himself as having a male gender with the possible need of testosterone replacement. Further family screening for CAH and the possibility of parental consanguinity could not be delineated because the patient was an orphan.
Discussion
We report a case of simple virilising form of CAH due to 21-OHD in a 66-year-old Chinese subject with a mosaic Turner karyotype. This condition is one of the most common autosomal recessive disorders of impaired cortisol biosynthesis. As a result of 21-OHD, adrenal synthesis of cortisol and in most cases also that of aldosterone is impaired. The consequential increased secretion of ACTH leads to adrenal hyperplasia and accumulation of cortisol precursors that are diverted to androgen production. Depending on the degree of enzyme deficiency, the CAH genotype can have several phenotypes. One is a salt-wasting type with a potential for a lifethreatening salt-wasting crisis during the neonatal period in addition to prenatal virilisation in females. The other phenotype is a simple virilising type with prenatal or postnatal virilisation in females or pseudoprecocious puberty in males. Also there is a non-classical type with pseudoprecocious puberty, hirsutism, acne, and subfertility in females.
1 Disease severity correlates with CYP21A2 allelic variation, located on chromosome 6, with an 80 to 90% genotype-phenotype correlation. 2 The prevalence of classical 21-OHD has been reported to be 1:10 000 Turner's syndrome (TS) has an estimated point prevalence of 1 in 2500 to 1 in 3000 liveborn phenotypic females, and is characterised by short stature, primary gonadal failure, and a wide spectrum of clinical features. 3 There is also a wide range of karyotypes, in which half of them have the classical monosomy X (45,X) and others have various mosaicism for 45,X. Virilisation occurring in patients with TS should prompt a search for the Ychromosome-bearing cell line, as they are at risk of developing malignant gonadal tumours. If the existence of Y chromosome material cannot be identified by cytogenetic or molecular analysis, the rare occurrence of co-existing CAH should be looked for to account for virilisation and/or sexual ambiguity.
So far, only six cases with both TS and CAH have been reported in the literature. [4] [5] [6] [7] [8] [9] Except for one case 4 presenting with diminished endometrial receptivity during in-vitro fertilisation in a 28-yearold woman, they all presented with different degrees of virilisation in phenotypic females. All except one case had a mosaic Turner karyotype. 5 The age of presentation varied from 1 to 28 years, depending on the degree of 21-OHD. The 1-year-old Caucasian girl presented with disordered sexual development and moderate salt-wasting episodes early in the neonatal period. 6 She was diagnosed to have mosaic Turner karyotype with 45,X/46,XX (5:11) and 21-OHD with elevated 17-OHP, androstenedione, and testosterone. Another case was a 23-year-old woman who presented with primary amenorrhoea, a phallus 3 cm in length, a urogenital sinus, and a 45,X/46XX karyotype. 7 The remaining two cases presented with clitoromegaly and mosaic TS in an 8-year-old 8 as well as a 5-year-old girl. 9 Our patient had the most advanced type of virilisation (Prader stage IV) and the latest presentation which might have been related to his reluctance in seeking medical care and the absence of salt-wasting episodes. Were it not due to the huge ovarian cyst, his intriguing medical condition might never have been exposed. In fact, the development of a large ovarian cyst in a 22-yearold Japanese woman with 21-OHD has already been reported. 10 In that case, the 8.5 x 6.2 cm ovarian cyst disappeared once hyperandrogenism was controlled with glucocorticoid therapy adjustment, and it was postulated that prolonged hyperandrogenism may have contributed to its development. 10 Another distinctive feature of our patient was his exceptionally short stature. The final body heights of patients with untreated mosaic TS and Y chromosome material are usually higher. 3 It is difficult to diagnose co-existing CAH, particularly the non-classical type, in patients with TS, as typical signs such as short stature, menstrual irregularities, primary infertility, and hirsutism may be present in both diseases. Therefore, it is important to measure 17-OHP levels in patients with TS, especially in the presence of moderate-to-severe hirsutism or virilisation. Although basal or ACTH-stimulated 17-OHP levels in patients with TS may only overlap with that of heterozygous 21-OHD patients, 11 17-OHP levels of our patient (particularly the stimulated level) clearly fell into the diagnostic range of classic CAH. 1 If 17-OHP values are non-diagnostic, the importance USP by GC-MS and mutational analysis to confirm CAH in patients with TS cannot be overemphasised. Apart from its significance in gender assignment and appropriate reconstructive surgery, early diagnosis of co-existing CAH is also important for proper management of growth failure; unopposed hyperandrogenism may lead to initial skeletal maturation which masks the growth disorder. However, premature closure of growth plates leads to short final heights, as seen in our patient.
More than 100 CYP21A2 mutations have been reported. 12 Mutational analysis in our patient revealed gross deletion/conversion of the promoter to exon 4 in one allele and hemizygous p.Ile172Asn mutation in the other allele. The former accounted for 27% and the latter 16% of all the mutations detected in 35 Chinese patients in a local study. 13 The missense mutation p.Ile172Asn is known to retain 1 to 2% of normal 21-hydroxylase activity and results in simple virilising CAH, compatible with the phenotype of our patient.
Conclusion
We have reported a case of mosaic TS and simple virilising form of CAH, who presented with a huge ovarian cyst. Although it is rare, co-existing CAH should be suspected in patients with TS and various degrees of virilisation, after the presence of Y chromosome material has been ruled out. 
